Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Swedish Orphan Biovitrum (BIOVF) had Current Ratio of 1.04 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$2.46B |
|
$367.52M |
|
$547.26M |
|
$1.91B |
|
$1.93B |
|
$532.22M |
|
$-115.32M |
|
$416.90M |
|
$416.90M |
|
$366.95M |
|
$366.95M |
|
$366.95M |
|
$366.95M |
|
$532.22M |
|
$880.25M |
|
341.73M |
|
345.56M |
|
$1.08 |
|
$1.06 |
|
| Balance Sheet Financials | |
$1.25B |
|
$149.85M |
|
$5.89B |
|
$7.14B |
|
$1.19B |
|
$1.17B |
|
$2.13B |
|
$3.33B |
|
$3.81B |
|
$-1.77B |
|
$3.81B |
|
343.44M |
|
| Cash Flow Statement Financials | |
$698.90M |
|
$-292.41M |
|
$-378.49M |
|
$85.52M |
|
$107.84M |
|
$22.33M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.04 |
-- |
|
-- |
|
0.24 |
|
0.41 |
|
77.77% |
|
21.62% |
|
21.62% |
|
35.75% |
|
16.93% |
|
14.93% |
|
$682.82M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
1.39 |
|
4.65 |
|
78.53 |
|
9.63% |
|
-20.77% |
|
5.14% |
|
7.36% |
|
$11.10 |
|
$1.98 |
|
$2.02 |
|